Physician profile
Gregg S Landis
NPI 1932156916
$233,491.99
in general payments reported to CMS, 2019-2025
16 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,870 · 2020: $14K · 2021: $15K · 2022: $35K · 2023: $18K · 2024: $36K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Consulting Fee: $49K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $22K · Travel and Lodging: $20K · Food and Beverage: $10K · Education: $5.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,995.00 |
| Consulting Fee | $48,825.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,087.50 |
| Travel and Lodging | $20,268.47 |
| Food and Beverage | $10,194.59 |
| Education | $5.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $68,159.12 | 2023-2025 | Enroute Transcarotid Neuroprotection System, General - Therapies, Enroute Transcarotid Stent |
| Silk Road Medical, INC. | $59,339.19 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $34,552.78 | 2022-2025 | Mo.Ma Ultra, Valiant Captivia, Venaseal |
| Bolton Medical INC | $30,516.98 | 2020-2024 | Treo Abdominal Stent-Graft System |
| Cook Incorporated | $21,935.00 | 2019-2024 | Zenith Alpha |
| Contego Medical, INC | $9,259.91 | 2024-2025 | Neuroguard Direct |
| Cook Medical LLC | $3,214.68 | 2019-2025 | Zenith Spiral-Z, Zenith, Cook |
| Endologix LLC | $1,713.19 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Inari Medical, INC. | $1,672.99 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Limflow System |
| W. L. Gore & Associates, INC. | $880.02 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Propaten Vascular Graft |
| Medtronic Vascular, INC. | $593.52 | 2019-2020 | |
| Abbott Laboratories | $563.15 | 2022-2024 | Esprit, Jeti Peripheral Catheter, Jeti |
| Cvrx, INC. | $443.62 | 2023-2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $430.27 | 2022 | |
| Stryker Corporation | $115.99 | 2023 | Citrefix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $101.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Landis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.